The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploratory study investigating the efficacy and safety of olanzapine prophylaxis for opioid-induced nausea and vomiting (JORTC-PAL20).
 
Eriko Satomi
Honoraria - Abbott Japan (I); Bayer (I); Boehringer Ingelheim (I); Boston Scientific (I); Bristol-Myers Squibb (I); Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo (I); Eisai; Eisai (I); Fukuda Denshi (I); Hisamitsu Pharmaceutical; Johnson & Johnson (I); Kyowa Kirin International; Medtronic (I); Medtronic (I); Mylan; Otsuka (I); Pfizer; Pfizer (I); Shionogi; St. Jude Medical (I); TERUMO; Terumo (I); TOA EIYO (I); Tsumura & Co.; Tsumura & Co.
Consulting or Advisory Role - Japan Lifeline (I)
Research Funding - Biotronik International (I)
 
Ayaka Ishikawa
No Relationships to Disclose
 
Sayaka Arakawa
No Relationships to Disclose
 
Hiroto Ishiki
Speakers' Bureau - Daiichi Sankyo/Lilly; EA Pharma; Hisamitsu Pharmaceutical; Mundipharma; Pfizer; Shionogi
 
Koji Amano
No Relationships to Disclose
 
Tomomi Kobayashi
No Relationships to Disclose
 
Naomi Sakiyama
No Relationships to Disclose
 
Ryo Otsuka
No Relationships to Disclose
 
Makoto Maeda
No Relationships to Disclose
 
Hironobu Hashimoto
No Relationships to Disclose
 
Shunsuke Oyamada
Honoraria - Chugai Pharma
 
Keisuke Ariyoshi
No Relationships to Disclose
 
Kota Kihara
No Relationships to Disclose
 
Akio Mizushima
No Relationships to Disclose